Monovalent Antibody Design and Mechanism of Action of Onartuzumab, a MET Antagonist With Anti-Tumor Activity as a Therapeutic Agent
Proceedings of the National Academy of Sciences of the United States of America - United States
doi 10.1073/pnas.1302725110
Full Text
Open PDFAbstract
Available in full text
Categories
Date
July 23, 2013
Authors
Publisher
Proceedings of the National Academy of Sciences